Lesion macrophages are a key target for the antiatherogenic effects of LXR agonists

Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):10-1. doi: 10.1161/01.ATV.0000152727.69018.61.
No abstract available

Publication types

  • Editorial
  • Review
  • Comment

MeSH terms

  • Animals
  • Arteriosclerosis / pathology
  • Arteriosclerosis / prevention & control*
  • DNA-Binding Proteins / agonists*
  • Humans
  • Hypolipidemic Agents / pharmacology*
  • Liver X Receptors
  • Macrophages / drug effects*
  • Orphan Nuclear Receptors
  • Receptors, Cytoplasmic and Nuclear / agonists*

Substances

  • DNA-Binding Proteins
  • Hypolipidemic Agents
  • Liver X Receptors
  • Orphan Nuclear Receptors
  • Receptors, Cytoplasmic and Nuclear